Book Value per Share: Sanara (SMTI)

Graphic logo of Sanara MedTech (SMTI)

Sanara MedTech Inc. (SMTI) occupies the high-tech surgery and tissue regeneration niche, offering B2B solutions to accelerate the healing of injuries. This chart shows the market price on GURU.Markets is 0.86, while the company generates revenue from supplying biomaterials to hospitals and clinics. Despite the risks of business dependency on CellerateRX and pressure from Medicare, the expansion of the distribution network across medical centers stabilizes performance.

Sanara (SMTI): Share Book Value from 07/04/2022 to 10/28/2026

Sanara MedTech, Inc. - analytical breakdowns and key metrics (SMTI)

- price and consensus price forecast:
Stock Quotes Sanara|SMTI - Analyst Forecast Prices
- market capitalization data:
Market Capitalization Sanara MedTech Inc.|SMTI - Company Buyout Price
- book capitalization data:
Net Assets per Single Share Sanara MedTech|SMTI - Net Asset Value|Market Capitalization to Book Value Ratio sanaramedtech.com|SMTI - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Sanara MedTech Inc.|SMTI - Long-Term Debt to Capital|Short-Term Debt to Equity Sanara|SMTI - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Sanara MedTech Inc.
Fundamental company valuation:sanaramedtech.com - SMTI
Manufactured products of Sanara

The investment attractiveness of Sanara MedTech Inc. (SMTI) is based on production automation via robotic bioreactors and AI-driven logistics management, which directly impacts the capitalization of tangible assets. An analysis of the book value per share allows for an assessment of the residual value of the owner's stake by dividing total equity by the number of shares outstanding, confirming the company's fundamental stability and the level of investment protection against devaluation.

Competitors of Sanara MedTech Inc. (SMTI)

Accounting Value per Share Krystal Corp KRYS|APGE - Book Price of a Share|Arcutis Biotherapeutics - Book Value per Share|VCEL (vcel.com) - Net Assets per Share|Net Assets per Single Share Oruka Therapeutics ORKA|Share Book Value DBV Technologies SA|Solesence Inc (SLSN) - Book Value per Share|Accounting Value of a Share journeymedicalcorp.com (DERM)|Book Value per Share FBRX (Forte Biosciences, Inc.)|empro.my - Book Value per Share|Net Assets per Single Share Sol-Gel Technologies Ltd. (SLGL)|AXIL: Accounting Value of a Share|MDCX (Medicus Pharma Limited) - Net Assets per Single Share|Verrica Pharmaceuticals Inc. (VRCA) - Accounting Value per Share|HOTH (Hoth Therapeutics Inc.) - Book Value per Share|Book Value per Share Biofrontera Inc (BFRI)|VYNE Therapeutics (VYNE) - Accounting Value per Share|Accounting Value of a Share SNOA (sonomapharma.com)|Net Assets per Single Share QNRX|Azitra Corporation - Net Assets per Share|Dermata Therapeutics - Net Assets per Single Share|ELAB - Book Value per Share|Revance Therapeutics, Inc. - Book Value per Share